InhibrxInc Sales per Share vs Profit Margin Analysis

INBX Stock  USD 35.15  0.08  0.23%   
Trend analysis of InhibrxInc balance sheet accounts such as Other Liabilities of 120.2 K or Net Tangible Assets of 70.1 M provides information on InhibrxInc's total assets, liabilities, and equity, which is the actual value of InhibrxInc to its prevalent stockholders. By breaking down trends over time using InhibrxInc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.

About InhibrxInc Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of InhibrxInc at a specified time, usually calculated after every quarter, six months, or one year. InhibrxInc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of InhibrxInc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which InhibrxInc currently owns. An asset can also be divided into two categories, current and non-current.

InhibrxInc Balance Sheet Chart

InhibrxInc Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how InhibrxInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, InhibrxInc's Cash And Short Term Investments are fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 323.3 M in 2024, whereas Other Liabilities is likely to drop slightly above 120.2 K in 2024.

Total Current Liabilities

Total Current Liabilities is an item on InhibrxInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of InhibrxInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents InhibrxInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of InhibrxInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from InhibrxInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 210 M in 2024, whereas Tax Provision is likely to drop 2,565 in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses83.7M131.3M219.8M230.8M
Cost Of Revenue2.7M2.8M1.2M1.1M

InhibrxInc fundamental ratios Correlations

0.98-0.060.69-0.980.680.270.930.170.930.920.650.64-0.53-0.720.920.720.920.92-0.220.780.75-0.090.970.790.9
0.980.090.64-0.950.790.380.90.350.910.880.650.76-0.42-0.740.90.820.880.9-0.250.720.75-0.210.940.80.86
-0.060.09-0.460.10.120.17-0.160.69-0.13-0.1-0.370.520.830.23-0.150.4-0.12-0.15-0.39-0.220.09-0.19-0.170.1-0.23
0.690.64-0.46-0.720.670.530.810.140.810.680.980.47-0.71-0.940.810.530.680.81-0.020.610.46-0.420.810.50.84
-0.98-0.950.1-0.72-0.7-0.2-0.97-0.17-0.97-0.97-0.7-0.650.570.76-0.97-0.76-0.97-0.970.26-0.88-0.840.02-0.99-0.87-0.94
0.680.790.120.67-0.70.670.740.640.750.620.770.84-0.34-0.860.740.890.620.74-0.160.520.61-0.560.720.670.7
0.270.380.170.53-0.20.670.290.60.30.10.590.56-0.02-0.640.30.480.090.3-0.09-0.120.0-0.980.270.070.31
0.930.9-0.160.81-0.970.740.290.181.00.970.810.65-0.62-0.851.00.760.971.0-0.360.840.84-0.130.980.860.99
0.170.350.690.14-0.170.640.60.180.210.080.280.840.46-0.380.190.750.070.19-0.120.020.16-0.580.170.210.1
0.930.91-0.130.81-0.970.750.31.00.210.970.810.68-0.6-0.861.00.780.971.0-0.360.840.85-0.140.980.870.99
0.920.88-0.10.68-0.970.620.10.970.080.970.660.59-0.57-0.710.970.711.00.97-0.440.880.90.060.960.910.96
0.650.65-0.370.98-0.70.770.590.810.280.810.660.56-0.65-0.980.820.620.670.82-0.080.590.49-0.490.790.530.83
0.640.760.520.47-0.650.840.560.650.840.680.590.560.09-0.680.660.980.580.66-0.30.480.61-0.460.640.660.59
-0.53-0.420.83-0.710.57-0.34-0.02-0.620.46-0.6-0.57-0.650.090.59-0.62-0.08-0.59-0.62-0.08-0.57-0.39-0.08-0.62-0.39-0.67
-0.72-0.740.23-0.940.76-0.86-0.64-0.85-0.38-0.86-0.71-0.98-0.680.59-0.86-0.74-0.72-0.860.16-0.61-0.570.53-0.83-0.62-0.87
0.920.9-0.150.81-0.970.740.31.00.191.00.970.820.66-0.62-0.860.770.971.0-0.370.840.84-0.140.980.860.99
0.720.820.40.53-0.760.890.480.760.750.780.710.620.98-0.08-0.740.770.70.77-0.320.620.74-0.360.740.780.7
0.920.88-0.120.68-0.970.620.090.970.070.971.00.670.58-0.59-0.720.970.70.97-0.430.880.90.070.960.90.96
0.920.9-0.150.81-0.970.740.31.00.191.00.970.820.66-0.62-0.861.00.770.97-0.370.840.84-0.140.980.860.99
-0.22-0.25-0.39-0.020.26-0.16-0.09-0.36-0.12-0.36-0.44-0.08-0.3-0.080.16-0.37-0.32-0.43-0.37-0.09-0.470.06-0.24-0.42-0.38
0.780.72-0.220.61-0.880.52-0.120.840.020.840.880.590.48-0.57-0.610.840.620.880.84-0.090.880.270.850.890.82
0.750.750.090.46-0.840.610.00.840.160.850.90.490.61-0.39-0.570.840.740.90.84-0.470.880.130.790.990.82
-0.09-0.21-0.19-0.420.02-0.56-0.98-0.13-0.58-0.140.06-0.49-0.46-0.080.53-0.14-0.360.07-0.140.060.270.13-0.10.06-0.16
0.970.94-0.170.81-0.990.720.270.980.170.980.960.790.64-0.62-0.830.980.740.960.98-0.240.850.79-0.10.820.97
0.790.80.10.5-0.870.670.070.860.210.870.910.530.66-0.39-0.620.860.780.90.86-0.420.890.990.060.820.83
0.90.86-0.230.84-0.940.70.310.990.10.990.960.830.59-0.67-0.870.990.70.960.99-0.380.820.82-0.160.970.83
Click cells to compare fundamentals

InhibrxInc Account Relationship Matchups

InhibrxInc fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab4.8M13.4M9.6M17.2M43.3M45.5M
Total Current Liabilities20.6M31.4M22.5M27.6M56.3M59.1M
Other Liab363K2.9M917K110K126.5K120.2K
Net Tangible Assets(93.6M)75.5M52.4M58.1M66.8M70.1M
Retained Earnings(69.3M)(145.4M)(227.1M)(372.4M)(613.7M)(583.0M)
Accounts Payable3.1M13.5M9.1M8.3M11.0M7.2M
Other Current Assets376K132.2M7.8M6.6M16.7M22.7M
Total Current Assets15.6M132.2M139.1M280.5M295.4M310.1M
Property Plant Equipment10.7M11.3M9.5M2.5M2.9M2.7M
Total Assets26.5M143.7M150.5M290.9M307.9M323.3M
Short Long Term Debt Total41.7M37.5M70.5M202.1M210.1M220.6M
Total Stockholder Equity(93.6M)75.5M52.4M58.1M43.5M45.7M
Property Plant And Equipment Net10.7M11.3M9.5M7.2M9.4M8.2M
Current Deferred Revenue7.9M3.1M2.0M166K149.4K141.9K
Net Debt30.2M(91.2M)(60.8M)(71.8M)(67.8M)(64.4M)
Cash11.5M128.7M131.3M273.9M277.9M291.8M
Non Current Assets Total10.9M11.6M11.3M10.4M12.5M9.9M
Long Term Debt30.4M29.2M70.5M202.1M207.0M217.3M
Cash And Short Term Investments11.5M128.7M131.3M273.9M277.9M291.8M
Net Receivables438K615K878K257K778K497.4K
Liabilities And Stockholders Equity26.5M143.7M150.5M290.9M307.9M323.3M
Non Current Liabilities Total99.5M36.9M75.6M205.2M208.1M111.2M
Capital Lease Obligations7.8M8.2M6.7M5.0M3.2M4.9M
Inventory3.2M(129.3M)(878K)(257K)(231.3K)(242.9K)
Other Stockholder Equity(24.3M)220.8M279.5M430.4M657.2M690.1M
Total Liab120.1M68.3M98.1M232.8M264.4M140.0M
Net Invested Capital(59.6M)104.7M70.5M260.1M250.5M263.0M
Property Plant And Equipment Gross10.7M11.3M3.2M2.5M16.1M16.9M
Accumulated Other Comprehensive Income(1.7M)(59.5M)(143.7M)(150.5M)(135.4M)(128.6M)
Net Working Capital(5.0M)100.8M116.7M252.9M239.0M251.0M
Short Term Debt4.7M1.5M1.7M1.9M2.1M2.6M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether InhibrxInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of InhibrxInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inhibrxinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inhibrxinc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.
Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for InhibrxInc Stock analysis

When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.12)
Revenue Per Share
0.038
Quarterly Revenue Growth
4.964
Return On Assets
(0.46)
Return On Equity
(4.75)
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.